Install
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
- 78articles · 30d
- 1+ day agolatest article
- Aug 17, 2026earliest in window
- 94%with images
- 86avg words
- Health & Wellness 64
- Medical 56
- Health 28
- Science & Technology 27
- Economy, Business & Finance 19
- Finance & Business 15
- Business & Industrial 10
- Science & Nature 5
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Akeso details survival win for its PD-1xVEGF drug versus Keytruda
1+ day, 16+ hour ago (76+ words) Endpoints News Akeso details survival win for its PD-1xVEGF drug versus Keytruda Akeso and Summit Therapeutics claimed a key win over Keytruda at the start of September,…...
How past Endpoints 11 winners fared as the biotech industry rebounded
4+ day, 3+ hour ago (64+ words) Endpoints News How past Endpoints 11 winners fared as the biotech industry rebounded We’ll be unveiling this year’s Endpoints 11 in Boston on the night of Sept. 24. Join us. Think we're worth reading…...
Shionogi's stroke drug fails mid-stage; Bayer's Hyrnuo gets expanded label in NSCLC
4+ day, 3+ hour ago (52+ words) Endpoints News Shionogi's stroke drug fails mid-stage; Bayer's Hyrnuo gets expanded label in NSCLC Plus news about Tevard Biosciences, Disc Medicine, InduPro, EMD Serono and Frazier Life Sciences....
FDA places partial hold on Biohaven's ion channel drug
4+ day, 4+ hour ago (77+ words) FDA places partial hold on Biohaven’s ion channel drug Endpoints News FDA places partial hold on Biohaven's ion channel drug The FDA has placed a troubled Biohaven program on partial clinical…...
Pharvaris' stock jumps on pivotal success in rare genetic disease
5+ day, 23+ hour ago (157+ words) Pharvaris’ stock jumps on pivotal success in rare genetic disease Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt out of these…...
Expanding its biopharma plans, Anthropic looks for a life-sciences dealmaker
6+ day, 2+ hour ago (92+ words) Endpoints News Expanding its biopharma plans, Anthropic looks for a life-sciences dealmaker Anthropic’s newest job posting confirms the company’s biotech dealmaking ambi…...
Moonwalk raises $70M to test siRNA treatment for obesity
6+ day, 6+ hour ago (75+ words) Endpoints News Moonwalk raises $70M to test siRNA treatment for obesity Moonwalk Biosciences is heading to the clinic with an obesity program and has raised $70 million for…...
Roivant reports Phase 2 win for lung disease drug that it got from Bayer
6+ day, 8+ hour ago (151+ words) #ERS26: Roivant reports Phase 2 win for lung disease drug that it got from Bayer Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt…...
FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote
1+ week, 1+ hour ago (82+ words) Endpoints News FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote AstraZeneca clinched an FDA accelerated approval for its oral SERD in certain…...
CAR-T deaths prompt halt by Novartis; Eli Lilly’s 13th acquisition of 2026; and more
1+ week, 2+ day ago (91+ words) Endpoints News CAR-T deaths prompt halt by Novartis; Eli Lilly’s 13th acquisition of 2026; and more Welcome back to Endpoints Weekly. Endpoints News broke the news this week on the deaths of…...